Stress chaperones, mortalin, and pex19p mediate 5-aza-2' deoxycytidine-induced senescence of cancer cells by DNA methylation-independent pathway

J Gerontol A Biol Sci Med Sci. 2007 Mar;62(3):246-55. doi: 10.1093/gerona/62.3.246.

Abstract

DNA demethylating agents are used to reverse epigenetic silencing of tumor suppressors in cancer therapeutics. Understanding of the molecular and cellular factors involved in DNA demethylation-induced gene desilencing and senescence is still limited. We have tested the involvement of two stress chaperones, Pex19p and mortalin, in 5-Aza-2' deoxycytidine (5AZA-dC; DNA demethylating agent)-induced senescence. We found that the cells overexpressing these chaperones were highly sensitive to 5AZA-dC, and their partial silencing eliminated 5AZA-dC-induced senescence in human osteosarcoma cells. We demonstrate that these chaperones modulate the demethylation and chromatin remodeling-dependent (as accessed by p16(INK4A) expression) and remodeling-independent (such as activation of tumor suppressor p53 pathway) senescence response of cells. Furthermore, we found the direct interactions of 5AZA-dC with these chaperones that may alter their functions. We conclude that both mortalin and Pex19p are important mediators, prognostic indicators, and tailoring tools for 5AZA-dC-induced senescence in cancer cells.

MeSH terms

  • Antimetabolites, Antineoplastic / pharmacology*
  • Azacitidine / analogs & derivatives*
  • Azacitidine / pharmacology
  • Biomarkers / analysis
  • Biomarkers, Tumor / analysis
  • Cell Line, Tumor
  • Cellular Senescence / drug effects*
  • Chromatin / drug effects
  • Chromatin Assembly and Disassembly / drug effects
  • Cyclin-Dependent Kinase Inhibitor p16 / drug effects
  • Cyclin-Dependent Kinase Inhibitor p16 / genetics
  • DNA Methylation / drug effects*
  • DNA Modification Methylases / antagonists & inhibitors*
  • Decitabine
  • Epigenesis, Genetic / drug effects
  • Gene Expression Regulation, Neoplastic / genetics
  • Gene Silencing / drug effects
  • Genes, p53 / genetics
  • HSP70 Heat-Shock Proteins / genetics
  • HSP70 Heat-Shock Proteins / pharmacology*
  • Heat-Shock Proteins / genetics
  • Heat-Shock Proteins / pharmacology*
  • Humans
  • Lipoproteins / genetics
  • Lipoproteins / pharmacology*
  • Membrane Proteins / genetics
  • Membrane Proteins / pharmacology*
  • Molecular Chaperones / genetics
  • Molecular Chaperones / pharmacology*
  • Osteosarcoma / pathology*
  • Tumor Suppressor Proteins / drug effects

Substances

  • Antimetabolites, Antineoplastic
  • Biomarkers
  • Biomarkers, Tumor
  • Chromatin
  • Cyclin-Dependent Kinase Inhibitor p16
  • HSP70 Heat-Shock Proteins
  • Heat-Shock Proteins
  • Lipoproteins
  • Membrane Proteins
  • Molecular Chaperones
  • Tumor Suppressor Proteins
  • mortalin
  • PEX19 protein, human
  • Decitabine
  • DNA Modification Methylases
  • Azacitidine